SCHEMBL30953477

SCHEMBL30953477

N[C@H](C(=O)Nc1cc(C(NC(=O)CCC(F)(F)F)C2CC2)ccn1)C1CCC(F)(F)CC1

nearest known ligand 0.34

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ NR3C2 P08235 2/20 0.34
▸ MEN1 O00255 1/20 0.32
▸ NPC1 O15118 1/20 0.32
▸ TP53 P04637 1/20 0.32
▸ TSHR P16473 1/20 0.32
▸ RAB9A P51151 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ USP30 Q70CQ3 1/20 0.32
▸ MASTL Q96GX5 1/20 0.31
▸ P2RX7 Q99572 2/20 0.31
▸ ANO1 Q5XXA6 1/20 0.31
▸ LNPEP Q9UIQ6 1/20 0.31
▸ GSK3B P49841 3/20 0.31
▸ DYRK1A Q13627 1/20 0.31
▸ PIK3C3 Q8NEB9 1/20 0.31
▸ TRPV1 Q8NER1 1/20 0.30
▸ MAPT P10636 1/20 0.30
▸ TGFBR1 P36897 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30953425 1.00 NR3C2 (0.34) NR3C2MEN1NPC1TP53TSHR
SCHEMBL30953241 0.92 ACACB (0.36) NR3C2MASTLP2RX7ANO1LNPEP
SCHEMBL30953277 0.90 ACACB (0.36) NR3C2MEN1NPC1TP53TSHR
SCHEMBL30953482 0.90 ACACB (0.36) NR3C2MEN1NPC1TP53TSHR
SCHEMBL30953361 0.89 RAB9A (0.35) NR3C2MEN1NPC1TP53TSHR
SCHEMBL30953451 0.89 NR3C2 (0.32) NR3C2MEN1NPC1TP53TSHR
SCHEMBL30953331 0.88 MEN1 (0.33) NR3C2MEN1NPC1TP53TSHR
SCHEMBL30953245 0.86 NR3C2 (0.36) NR3C2MEN1NPC1TP53TSHR
SCHEMBL30953251 0.85 MAPK1 (0.36) —
SCHEMBL30953125 0.84 AAK1 (0.41) MEN1NPC1TP53TSHRRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4630115-A1 THERAPEUTIC COMPOUNDS Sanofi (FR) 2025-10-15 — — EP disclosed
WO-2024121427-A1 THERAPEUTIC COMPOUNDS SANOFI (FR) 2024-06-13 — — WO disclosed
Send feedback